Johnson & Johnson trial shows vaccine effective, even against variants

Johnson & Johnson's single-shot coronavirus vaccine protected against symptomatic and asymptomatic infection, and prevented hospitalization and death in all participants 28 days after vaccination, according to new clinical trial results published Wednesday. The vaccine was 67 percent effective on average against moderate to severe–critical COVID-19 at least 14 days after administration.
Read more...

;